Long-term Follow-up Study of HTLV-I Infection in Bottle-fed Children Born to Seropositive Mothers

Ando, Yumiko; Matsumoto, Yoshinari; Nakano, Shiro; Saito, Kensuke; Kakimoto, Kazuhiro; Tanigawa, Takuo; Ekuni, Yutaka; Kawa, Motohiro; Toyama, Takenori

doi:10.1053/jinf.2002.1081

Cited by 14 publications

(8 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In some areas of Japan, seropositivity can be as high as 12% to 16%, but in South America, Africa, and some Caribbean countries the rates are 2% to 6%. * Ando et al 12,13 in two separate reports demonstrated a parallel decline in antibodies against HTLV-I in both formula-fed and breastfed infants to a nadir at approximately 1 year of age and a subsequent increase in antibodies from 1 to 2 years of age. 156 In blood donors in Europe, the seroprevalence of HTLV-I has been reported at 0.001% to 0.03%.…”

Section: Human T-cell Leukemia Virus Type Imentioning

confidence: 98%

See 1 more Smart Citation

Transmission of Infectious Diseases Through Breast Milk and Breastfeeding

Lawrence¹

2011

Breastfeeding

View full text Add to dashboard Cite

Section: Human T-cell Leukemia Virus Type Imentioning

confidence: 98%

“…156 In blood donors in Europe, the seroprevalence of HTLV-I has been reported at 0.001% to 0.03%. 12,13 Transmission of HTLV-I infection via breastfeeding is also clearly associated with the duration of breastfeeding. HTLV-1 is not a major disease in the United States.…”

Section: Human T-cell Leukemia Virus Type Imentioning

confidence: 99%

Transmission of Infectious Diseases Through Breast Milk and Breastfeeding

Lawrence¹

2011

Breastfeeding

View full text Add to dashboard Cite

“…Since breastfeeding is the main mother to child transmission route of HTLV-1/2 135,[199][200][201][202][203][204] and there is no vaccine against the infection or even any curative treatment, breastfeeding is contraindicated in mothers infected by the virus. For these women, the use of lactation inhibitors is recommended and the provision of infants with milk formula substitutes 2 .…”

Section: Pregnant Womenmentioning

confidence: 99%

Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection

Rosadas

Brites

Arakaki-Sanchéz

et al. 2021

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health. HTLV-1/2 infection is a public health problem globally, and Brazil has the largest number of individuals living with the virus. HTLV-1 causes several clinical manifestations of neoplasm (adult T-cell leukemia/lymphoma) and inflammatory nature, such as HTLV-1-associated myelopathy and other manifestations such as uveitis, arthritis, and infective dermatitis. These pathologies have high morbidity and mortality and negatively impact the quality of life of infected individuals. This review includes relevant information for health authorities professionals regarding viral transmission, diagnosis, treatment, and monitoring of individuals living with HTLV-1 and 2 in Brazil.

show abstract

“…23,197,198 Por lo tanto, la prevención de la transmisión vertical es de extrema importancia para reducir la incidencia de enfermedades asociadas al virus. 23,96,137 Como se sabe que la lactancia materna es la principal vía de transmisión vertical del HTLV-1/2 135,[199][200][201][202][203][204] y aún no existe una vacuna para combatir la infección, Carolina Rosadas y colaboradores ni siquiera un tratamiento curativo, la lactancia materna no está contraindicada en madres infectadas por el virus. Para estas mujeres, se recomienda el uso de inhibidores de la lactancia y el suministro de fórmulas lácteas infantiles.…”

Section: Gestantesunclassified

Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo vírus linfotrópico de células T humanas (HTLV)

Rosadas

Brites

Arakaki-Sanchéz

et al. 2021

Epidemiol. Serv. Saúde

View full text Add to dashboard Cite

Resumo O artigo aborda a infecção pelo vírus linfotrópico de células T humanas (human T lymphotropic virus, HTLV), tema contemplado no Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil. A infecção pelo HTLV-1/2 é um problema de saúde pública mundial, sendo o Brasil o país a referir o maior número de indivíduos convivendo com o vírus. O HTLV-1 causa diversas manifestações clínicas, de natureza neoplásica, como a leucemia/linfoma de células T do adulto, e de natureza inflamatória, a exemplo da mielopatia associada ao HTLV-1 e outras alterações, como uveíte, artrite e dermatite infecciosa. Estas patologias apresentam elevada morbimortalidade e impactam negativamente a qualidade de vida dos indivíduos infectados. A presente revisão inclui informações relevantes para gestores e profissionais de saúde sobre os mecanismos de transmissão viral, diagnóstico, tratamento e acompanhamento de indivíduos vivendo com o HTLV-1/2 no Brasil.

show abstract

Long-term Follow-up Study of HTLV-I Infection in Bottle-fed Children Born to Seropositive Mothers

Cited by 14 publications

References 8 publications

Transmission of Infectious Diseases Through Breast Milk and Breastfeeding

Transmission of Infectious Diseases Through Breast Milk and Breastfeeding

Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection

Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo vírus linfotrópico de células T humanas (HTLV)

Contact Info

Product

Resources

About